Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 1
1955 1
1957 5
1959 2
1960 5
1964 1
1965 2
1966 1
1968 1
1969 1
1970 3
1971 1
1974 1
1975 1
1977 1
1979 1
1980 1
1981 1
1982 3
1983 1
1984 3
1985 3
1986 3
1987 11
1988 24
1989 29
1990 25
1991 25
1992 4
1993 7
1994 6
1995 3
1996 8
1997 4
1998 4
1999 9
2000 6
2001 8
2002 7
2003 8
2004 19
2005 19
2006 19
2007 16
2008 24
2009 28
2010 24
2011 34
2012 40
2013 39
2014 44
2015 37
2016 42
2017 51
2018 48
2019 53
2020 90
2021 109
2022 85
2023 85
2024 58

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,081 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for moreau c
Search for Morerau C instead (1 results)
Trial of Deferiprone in Parkinson's Disease.
Devos D, Labreuche J, Rascol O, Corvol JC, Duhamel A, Guyon Delannoy P, Poewe W, Compta Y, Pavese N, Růžička E, Dušek P, Post B, Bloem BR, Berg D, Maetzler W, Otto M, Habert MO, Lehericy S, Ferreira J, Dodel R, Tranchant C, Eusebio A, Thobois S, Marques AR, Meissner WG, Ory-Magne F, Walter U, de Bie RMA, Gago M, Vilas D, Kulisevsky J, Januario C, Coelho MVS, Behnke S, Worth P, Seppi K, Ouk T, Potey C, Leclercq C, Viard R, Kuchcinski G, Lopes R, Pruvo JP, Pigny P, Garçon G, Simonin O, Carpentier J, Rolland AS, Nyholm D, Scherfler C, Mangin JF, Chupin M, Bordet R, Dexter DT, Fradette C, Spino M, Tricta F, Ayton S, Bush AI, Devedjian JC, Duce JA, Cabantchik I, Defebvre L, Deplanque D, Moreau C; FAIRPARK-II Study Group. Devos D, et al. Among authors: moreau c. N Engl J Med. 2022 Dec 1;387(22):2045-2055. doi: 10.1056/NEJMoa2209254. N Engl J Med. 2022. PMID: 36449420 Clinical Trial.
Thalamocortical organoids enable in vitro modeling of 22q11.2 microdeletion associated with neuropsychiatric disorders.
Shin D, Kim CN, Ross J, Hennick KM, Wu SR, Paranjape N, Leonard R, Wang JC, Keefe MG, Pavlovic BJ, Donohue KC, Moreau C, Wigdor EM, Larson HH, Allen DE, Cadwell CR, Bhaduri A, Popova G, Bearden CE, Pollen AA, Jacquemont S, Sanders SJ, Haussler D, Wiita AP, Frost NA, Sohal VS, Nowakowski TJ. Shin D, et al. Among authors: moreau c. Cell Stem Cell. 2024 Mar 7;31(3):421-432.e8. doi: 10.1016/j.stem.2024.01.010. Epub 2024 Feb 20. Cell Stem Cell. 2024. PMID: 38382530
Conservative Iron Chelation for Neuroferritinopathy.
Marchand F, Moreau C, Kuchcinski G, Huin V, Defebvre L, Devos D. Marchand F, et al. Among authors: moreau c. Mov Disord. 2022 Sep;37(9):1948-1952. doi: 10.1002/mds.29145. Epub 2022 Aug 22. Mov Disord. 2022. PMID: 35996824 Free PMC article.
Intracerebroventricular dopamine for Parkinson's disease.
Devos D, Devedjian JC, Moreau C. Devos D, et al. Among authors: moreau c. Oncotarget. 2017 Jul 11;8(28):45034-45035. doi: 10.18632/oncotarget.17596. Oncotarget. 2017. PMID: 28484085 Free PMC article. No abstract available.
Iron as a therapeutic target for Parkinson's disease.
Moreau C, Duce JA, Rascol O, Devedjian JC, Berg D, Dexter D, Cabantchik ZI, Bush AI, Devos D; FAIRPARK-II study group. Moreau C, et al. Mov Disord. 2018 Apr;33(4):568-574. doi: 10.1002/mds.27275. Epub 2018 Jan 30. Mov Disord. 2018. PMID: 29380903 Review. No abstract available.
1,081 results